MP Biomedicals is dedicated to giving scientists and researchers innovative, quality tools and superior service to aid them in their quest for ground-breaking discovery and turning the hope for life-changing solutions into a reality.

    Our roots go back more than 40 years to when Milan Panic founded ICN Pharmaceuticals in 1959 from the basement of his Pasadena home. Mr. Panic used his strategic vision to expand from California into Russia and China, placing ICN in a position to take advantage of the emerging world economy in the new millennium.

    In 2002, Mr. Panic stepped down as chairman and chief executive officer of ICN Pharmaceuticals and purchased MP Biomedicals. This experience, coupled with his acquisition of MP Biomedicals makes possible a new age of discovery in the life science and biotechnology industries.

    Today, the company manufactures and sells more than 55,000 products and is one of the only companies in the industry to offer a comprehensive line of life science, fine chemical and diagnostic products.

    MP Biomedicals is a world-wide corporation, with its headquarters located in Irvine, California and satellite offices in Europe, Asia and Australia. We also maintain a vast network of global distributors, including our ISO 9002 diagnostic products facility in Orangeburg, New York, and distribution centers in Aurora, Ohio and Burlingame, California.

    No matter how dynamic the evolution of the life science and biotechnology markets, we remain committed to supporting our customers in their efforts to make new discoveries. From basic research, through scale-up, to full-scale production and diagnostic testing, MP Biomedicals serves every industry need杅rom specialized areas of research to supplying large scale quantities of fine chemicals.

    Our customers partner with us because they want a long-time player and reliable colleague in the fields of life science research and diagnostics. MP Biomedicals will never rest in our odyssey to remain at the forefront of discovery in the ever-changing biomedical industry.